Apr 28, 2021 / NTS GMT
Unidentified Participant
Good afternoon, and welcome back, everyone at the LifeScience online days. We are here with Ilse Roodink from ImmunoPrecise Antibodies. And she'll be telling you more about how therapeutic antibodies can help us against SARS-CoV-2, and her colleague, Debby Kruijsen, is also here as a Moderator. So please don't hesitate to ask your questions in the chats. Please go ahead, Ilse.
Ilse Roodink - ImmunoPrecise Antibodies Ltd. - Scientific Director
Thank you. Dear attendees, thank you for taking the time to learn more about IPA SARS-CoV-2 therapeutic antibody program and our capabilities that underpin the identification of synergistic antibody cocktails targeting the spike glycoprotein.
I would also like to thanks, Sartorius, for giving us the opportunity to discuss in more detail how we're leveraging our multi-species antibody discovery platforms and high-throughput antibody characterization abilities businesses enabled us to formulate sensible therapeutic portfolios at an early stage. Thank you, Helena, for the introduction.
This is
Immunoprecise Antibodies Ltd LifeScience Webinar Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot